• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Economic incentives effective in increasing male circumcision rates in Kenya

byJeffrey CohenandPriyanka Vedak
August 2, 2014
in Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Economic incentives in the form of food vouchers covering the value of transportation, plus at least 1-2 days of lost work wages, was effective in increasing male circumcision rates in Kenya. 

2. This intervention was effective in increasing rates of circumcision among individuals at high risk of acquiring HIV. 

Evidence Rating Level:  2 (Good)           

Study Rundown: Male circumcision has been found to be an effective way of decreasing HIV transmission.  There are, however, several barriers to circumcision in Kenya, including the financial costs associated with the procedure.  This study randomized 1504 men from three districts in the Nyanza region of western Kenya to receive economic compensation for circumcision in the form of food vouchers of three different values or no voucher.  One group received vouchers worth the approximate travel cost to the clinic (about $2.50), one group received vouchers worth transportation cost plus 1-2 days of work wages ($8.75), and the third group received vouchers worth transportation plus 2-3 days of work wages ($15.00).

At two months, a greater proportion of individuals from the $8.75 and $15.00 groups were circumcised when compared to the $2.50 group and control group.  The intervention also increased circumcision among individuals at high risk of acquiring HIV.  Strengths of this study include the use of several different voucher values and the fact that the highest value ($15.00) was the approximate cost of circumcision to avoid coercion.  One weakness of the study is the use of household listings that were 3-8 months old, leading to an inability to find some individuals who had relocated.  This study shows that economic incentives can be useful in increasing the rates of male circumcision in Kenya, and more incentive schemes should be attempted to find the most effective one.

Click to read the study in JAMA

RELATED REPORTS

Weekly islatravir plus lenacapavir maintains HIV virologic suppression

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

Psychiatric and physical comorbidities continue to be prevalent amongst Canadians living with Human Immunodeficiency Virus

Relevant Reading: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

In-Depth [randomized controlled trial]: This study randomized 1504 men from three districts in Kenya to receive food vouchers of three different values ($2.50, $8.75, $15.00) or no voucher (control group) to undergo circumcision.   Those in the $2.50 group had circumcision rates similar to those in the control group (AOR 1.1, 95% CI 0.4-3.3, p=0.87).  Those in the $8.75 and $15.00 groups, however, had higher rates of circumcision than the control group (AOR 4.3, 95% CI 1.7-10.7, p=0.002 and AOR 6.2, 95% CI 2.6-15.0, p<0.001).  The outcomes in the $8.75 and $15.00 groups were comparable (Wald test p=0.2).  There was also an increase in the rate of circumcision among individuals at high risk of acquiring HIV.

More from this author: Ambulances equipped for thrombolysis allow for more rapid stroke treatment, No link between TNF-a inhibitor use and cancer in inflammatory bowel disease, Stem cell transplant may be effective in sickle cell disease, Varenicline (Chantix) with nicotine patches effective in smoking cessation, No benefit with hydroxychloroquine (Plaquenil) over placebo in Sjogren’s Syndrome [JOQUER Trial]

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: AIDScircumcisionHIV
Previous Post

The 3C Study: Alemtuzumab may reduce acute rejection following kidney transplant

Next Post

The CARESS trial: Dual antiplatelet therapy superior to monotherapy in symptomatic carotid stenosis [Classics Series]

RelatedReports

Few high school students, young adults get HIV testing
Chronic Disease

Weekly islatravir plus lenacapavir maintains HIV virologic suppression

December 22, 2025
Few high school students, young adults get HIV testing
Chronic Disease

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

August 22, 2025
Few high school students, young adults get HIV testing
Chronic Disease

Psychiatric and physical comorbidities continue to be prevalent amongst Canadians living with Human Immunodeficiency Virus

July 21, 2025
Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Second-line TAF-based ART improves viral suppression in pediatric HIV

June 4, 2025
Next Post
Classics Series, Landmark Trials in Medicine

The CARESS trial: Dual antiplatelet therapy superior to monotherapy in symptomatic carotid stenosis [Classics Series]

New dengue fever vaccine effective in phase 3 trial

2 Minute Medicine Rewind July 27 – August 3, 2014

Lower vulvar cancer-related mortality in African Americans

Severity of complications in pediatric influenza-like illness identified

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Adults with attention-deficit/hyperactivity disorder are at higher risk of poor long-term adherence to antihypertensive therapy
  • 150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults
  • 2 Minute Medicine: Pharma Roundup – Merck and Mayo Clinic’s AI precision medicine lab, Novartis’ remibrutinib hits Phase III hive endpoint, FDA grants priority review for iberdomide in myeloma, oral infigratinib boosts growth velocity in achondroplasia, and shingles vaccine/sildenafil linked to lower Alzheimer’s risk [February 2026]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.